$1.79
-0.03[-1.65%]
Last update: 4:00PM (Delayed 15-Minutes)
Get Real Time Here
Get Real Time Here
$1.83
0.0400[2.23%]
| Open1.830 | Close1.790 |
| Vol / Avg.188.281K / 236.737K | Mkt Cap85.568M |
| Day Range1.750 - 1.905 | 52 Wk Range1.670 - 11.710 |
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -
BioAtla Stock (NASDAQ:BCAB), Key Statistics
BioAtla Stock (NASDAQ: BCAB) analysis, key statistics.
Valuation Measures
Enterprise Value
-78.5M
Trailing P/E
- -
Forward P/E
- -
PE Ratio (TTM)
- -
PEG Ratio (TTM)
- -
Price / Sales (ttm)
- -
Price / Book (mrq)
0.7
Price / EBITDA
- -
Enterprise Value / EBITDA (TTM)
- -
Earnings Yield
-145.6%
Price change 1 M
- -
Stock Price History
Alpha
- -
Beta
- -
Balance Sheet
Book Value per share
2.6
Tangible Book value per share
2.6
Total Liabilities (Quarterly)
55.1M
Total Assets
179.6M
Total Liabilities
55.1M
Profitability
Net income Growth
- -
Gross Margin
- -
Net Margin
- -
EBIT Margin
- -
EBITDA Margin
- -
Operating Margin
- -